Background Image
Table of Contents Table of Contents
Previous Page  77 / 132 Next Page
Show Menu
Previous Page 77 / 132 Next Page
Page Background

2015 Annual Report


Risk Assessment

Management and

Research Outcomes





Laboratory and

Testing Network

Risk Communication

and Consumer



Cooperation and

Cross-Strait Exchange






Policy and








4. Prospective Topics on Genetically Modified Foods and Enhancing Risk Analysis


TFDA has added 100 items of risk assessment information which have been published them on

TFDA website for public perusal in order to enhance Taiwan's capacity for implementing food

safety risk assessments and management capacities of genetically modified (GMO) food products.

Besides, public health risk assessments have also been carried out for the intake of food products

containing GMO soybeans. The National Food Consumption Database has also been updated

with relevant food classification and food coding system. Risk communication and information

transmission of GMO food safety assessment topics were alsoin progress at the same time to

generate knowledge economy and value.

5. Project for the Integration and Improvement of Food-Borne Disease and Pathogen

Monitoring and Protection Network

To improve food product safety and management efficiency and ensure public food safety,

examining, monitoring of important foodborne pathogens and food sources are carried out to

assess the contamination of high-risk pathogens in food products and to strengthen management

of origin and self-management of food businesses. Continuous monitoring is also used to evaluate

the effectiveness of surveillance to prevent food contamination by medium-to-high-risk pathogens.

6. Integrated Project for Addictive Substances - A Study on the Management of

Controlled Drugs and Prevention of Drug Abuse


The Amended Draft for the Controlled Drugs Act

was completed and submitted for legislative

revision and reference. Drug abuse information from various departments and agencies was

compiled and analyzed to study relevant risk factors of drug abusing demographics in the Taiwan

region and to provide the country with empirical data for preventing drug abuse amongst high-risk


(2) In case of emergency, rapid data comparisons can be made. Optimized mass spectroscopy

parameters for standard sample testing and analysis methods for 203 types of controlled drugs

and emerging drugs of abuse were developed as well. Additionally, medicinal product information

for 258 types of emerging drugs of abuse or products that generate toxic metabolites (or contain

controlled ingredients) have been established, offering instant access to reference data.

7. A Study on Regulatory Management of Science for Nanotechnology Biomedical


(1) Relevant management specifications and risk assessment and management information from around

the world on nano-food and nano-medicinal products were collected to formulate a total of four

regulatory drafts for nano-foods and two regulatory drafts for nano-medicinal products, providing a

reference basis for formulating national nano-product management specifications in the future.

(2) TFDA testing capabilities for nano-plastics and composite materials as well as nano-medicinal

products were established to address potential future needs for monitoring the quality of

commercial food containers and nano-medicinal products.